CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Analyst Ratings

USA • NYSE Arca • NYSEARCA:CLDI • US3207034089

0.9877 USD
-0.03 (-3.17%)
At close: Feb 2, 2026
0.9846 USD
0 (-0.31%)
After Hours: 2/2/2026, 8:04:00 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CLDI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • CLDI was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CLDI.
  • In the previous month the buy percentage consensus was at a similar level.
  • CLDI was analyzed by 7 analysts. More opinions would make the average more meaningful.
CLDI Historical Analyst RatingsCLDI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6
CLDI Current Analyst RatingCLDI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-06-27 Ladenburg Thalmann Initiate Buy
2024-05-15 Baird Maintains Outperform -> Outperform
2024-03-21 Baird Maintains Outperform -> Outperform
2024-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-22 HC Wainwright & Co. Initiate Buy
2023-10-09 Baird Initiate Outperform

CALIDI BIOTHERAPEUTICS INC / CLDI FAQ

What is the consensus rating for CALIDI BIOTHERAPEUTICS INC (CLDI) stock?

The consensus rating for CALIDI BIOTHERAPEUTICS INC (CLDI) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.